Trial Profile
Clinical Trials Insight: 700013448
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 02 Sep 2008
Price :
$35
*
At a glance
- Drugs Anti-MRSA monoclonal antibody (Primary) ; Vancomycin (Primary)
- Indications Staphylococcal infections
- Focus Therapeutic Use
- Sponsors NeuTec Pharma
- 29 Aug 2008 Added ref 9092655.
- 20 Jun 2006 New trial record.